Mouthpiece With Integrated Cheek Support vs. Manual Cheek Support During Respiratory Oscillometry
Launched by POLITECNICO DI MILANO · Jul 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to support the cheeks of participants while measuring how well their lungs are working. The goal is to see how accurately lung function can be measured using a special technique called oscillometry, which helps assess respiratory health. Participants will experience two methods: one where an expert holds their cheeks manually (the traditional method) and another where a built-in cheek support is used in a mouthpiece.
The trial is open to individuals aged 5 to 75 years who can follow the study procedures. Participants can expect to help researchers understand which method provides more accurate lung measurements and which one is more comfortable. Additionally, the study will look at how different face sizes can affect the comfort of cheek support and any errors that might occur with the new mouthpiece. If you or someone you know is eligible and interested, this study could provide valuable insights into improving lung function tests.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects aged between 5 and 75 years
- Exclusion Criteria:
- • Subjects unable to follow the study procedures or with any physical or mental condition deemed unsuitable by the doctor will be excluded from the study
About Politecnico Di Milano
Politecnico di Milano is a prestigious technical university in Italy, renowned for its excellence in engineering, architecture, and design. As a clinical trial sponsor, Politecnico di Milano leverages its cutting-edge research capabilities and interdisciplinary expertise to advance innovative healthcare solutions. The institution is committed to enhancing medical knowledge through rigorous scientific inquiry and collaboration with healthcare professionals, industry partners, and academic institutions. By conducting clinical trials, Politecnico di Milano aims to contribute to the development of effective therapies and improve patient outcomes, while adhering to the highest ethical standards and regulatory guidelines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergamo, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported